Print

Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces Third Quarter 2012 Results  
11/13/2012 8:33:00 AM

VANCOUVER, British Columbia, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today its financial and operating results for the third quarter ended September 30, 2012 and provided a corporate update.
//-->